Swedens National Board of Health and Welfare explains that the reason behind the rollback is that little is known about the effects of these treatments over the long term and "the risks outweigh the benefits currently".
However, experts say those treatments were designed for exceptional cases in the first place.
"We had a protocol in place which was designed for very rare and extreme cases and suddenly the demand exploded so we continued to use that protocol, said Mikael Landen, a psychiatrist specialising in gender dysphoria who contributed to the scientific study on which Swedens health authority based its decision.
Maybe we shouldnt have done that. But I wouldnt be the one criticising the clinicians for doing that because it was difficult, they wanted to help these patients," he told AFP.
Sweden, like many other western countries, has in recent years seen a sharp rise in diagnoses of gender dysphoria.
According to the Swedish health authority, the trend is particularly visible among 13- to 17-year-olds assigned female at birth, with an increase of 1,500 per cent between 2008 and 2018.
Experts say the reasons for this increase remain largely a "mystery".
Is watching sales of amphetamines (Adderall, Concerta etc.) and benzos (Xanax, Ativan, Klonopin etc.) along with opiods.
So Drs and pharmacies are being careful with their purchases/scripts.
Profile InformationMember since: Sat Dec 6, 2008, 11:53 AM
Number of posts: 15,594
- 2023 (52)
- 2022 (43)
- 2021 (39)
- 2020 (40)
- 2019 (47)
- 2018 (18)
- 2017 (56)
- 2016 (48)
- 2015 (5)
- 2014 (25)
- 2013 (10)
- 2012 (5)